Publications

Nicholson, G. et al. (2021) “Local prevalence of transmissible SARS-CoV-2 infection: an integrative causal model for debiasing fine-scale targeted testing data”, p. 2021.05.17.21256818.

Wymant, C. et al. (2021) “The epidemiological impact of the NHS COVID-19 app”, Nature, 594(7863), pp. 408–412.

Wu, F. and Rebeschini, P. (2021) “Nearly Minimax-Optimal Rates for Noisy Sparse Phase Retrieval via Early-Stopped Mirror Descent”, arXiv.

Ward, H. et al. (2021) “Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: serial cross-sectional studies of 365,000 adults”, Lancet Regional Health - Europe, 4.

Christen, P. et al. (2021) “The J-IDEA Pandemic Planner”, Medical Care, 59(5), pp. 371–378.

Riley, S. et al. (2021) “Resurgence of SARS-CoV-2: detection by community viral surveillance”, Science, 372(6545), pp. 990–995.

Riley, S. et al. (2021) “REal-time Assessment of Community Transmission (REACT) of SARS-CoV-2 virus: Study protocol”, Wellcome Open Research, 5, p. 200.

Ragonnet-Cronin, M. et al. (2021) “Genetic evidence for the association between COVID-19 epidemic severity and timing of non-pharmaceutical interventions”, Nature Communications, 12.

McCabe, R. et al. (2021) “Modelling ICU capacity under different epidemiological scenarios of the COVID-19 pandemic in three western European countries”, International Journal of Epidemiology, 50(3), pp. 753–767.

Djaafara, B. et al. (2021) “A Quantitative Framework for Defining the End of an Infectious Disease Outbreak: Application to Ebola Virus Disease”, American Journal of Epidemiology, 190(4), pp. 642–651.